全文获取类型
收费全文 | 1850篇 |
免费 | 81篇 |
国内免费 | 64篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 9篇 |
妇产科学 | 8篇 |
基础医学 | 184篇 |
口腔科学 | 7篇 |
临床医学 | 98篇 |
内科学 | 223篇 |
皮肤病学 | 6篇 |
神经病学 | 693篇 |
特种医学 | 22篇 |
外科学 | 101篇 |
综合类 | 174篇 |
预防医学 | 17篇 |
眼科学 | 7篇 |
药学 | 374篇 |
中国医学 | 54篇 |
肿瘤学 | 14篇 |
出版年
2023年 | 4篇 |
2022年 | 12篇 |
2021年 | 16篇 |
2020年 | 17篇 |
2019年 | 24篇 |
2018年 | 23篇 |
2017年 | 23篇 |
2016年 | 36篇 |
2015年 | 30篇 |
2014年 | 51篇 |
2013年 | 104篇 |
2012年 | 78篇 |
2011年 | 80篇 |
2010年 | 59篇 |
2009年 | 61篇 |
2008年 | 71篇 |
2007年 | 49篇 |
2006年 | 52篇 |
2005年 | 54篇 |
2004年 | 45篇 |
2003年 | 51篇 |
2002年 | 53篇 |
2001年 | 43篇 |
2000年 | 33篇 |
1999年 | 21篇 |
1998年 | 30篇 |
1997年 | 38篇 |
1996年 | 49篇 |
1995年 | 48篇 |
1994年 | 41篇 |
1993年 | 28篇 |
1992年 | 35篇 |
1991年 | 32篇 |
1990年 | 31篇 |
1989年 | 30篇 |
1988年 | 27篇 |
1987年 | 27篇 |
1986年 | 40篇 |
1985年 | 79篇 |
1984年 | 74篇 |
1983年 | 59篇 |
1982年 | 52篇 |
1981年 | 66篇 |
1980年 | 44篇 |
1979年 | 30篇 |
1978年 | 12篇 |
1977年 | 9篇 |
1976年 | 5篇 |
1974年 | 5篇 |
1970年 | 3篇 |
排序方式: 共有1995条查询结果,搜索用时 31 毫秒
1.
CROSSOVER COMPARISON BETWEEN THE DEPRESSOR EFFECTS OF LOW AND HIGH WORK-RATE EXERCISE IN MILD HYPERTENSION 总被引:2,自引:0,他引:2
Eiichiro Tashiro Shin-ichiro Miura Manabu Koga Manabu Sasaguri Munehito Ideishi Masaharu Ikeda Hiroaki Tanaka Munehiro Shindo Kikuo Arakawa 《Clinical and experimental pharmacology & physiology》1993,20(11):689-696
1. The relationship between work-rate and the antihypertensive effect of exercise in hypertensives, and the mechanism of that effect, were investigated by a crossover clinical trial. 2. Ten mild hypertensives were randomly divided into two groups. One group performed low work-rate exercise (LWE) on a cycle ergometer for 10 weeks (blood lactate threshold; ~50% of maximum oxygen consumption [V?O2max]). After a 10 week interval without exercise training, these subjects were then switched to a high work-rate exercise (HWE) regimen (4 mmol/ L of blood lactate; ~75% of V?O2max) for another 10 weeks. In the other group, the order of exercise training was reversed. Since two patients withdrew from the protocol during HWE periods, statistical analysis was performed on the data from the remaining eight patients. There were no order effects observed in any of the data from the two groups. 3. During both LWE and HWE, resting blood pressure (BP) fell significantly after the initiation of exercise therapy (P<0.05). Furthermore, the overall effects of 10 weeks of LWE and HWE on BP were not significantly different. 4. The work-rate at the lactate threshold, which reflects physical fitness, had increased significantly by 16 W (P<0.01) after the LWE period and by 11 W (P<0.01) after the HWE. 5. During the LWE period, changes in haemodynamic and humoral variables were not significant, except for a reduction in plasma norepinephrine at week 10 (P<0.05). In the HWE period, changes in haemodynamic and humoral variables were not significant. 6. Based on these findings, LWE is recommended for mild hypertensives because of its safety. 相似文献
2.
Modulating effects of posttraining epinephrine on memory: Involvement of the amygdala noradrenergic system 总被引:5,自引:0,他引:5
These experiments examined the effects, on retention, of posttraining intra-amygdala administration of norepinephrine (NE), and propranolol. Rats were trained on a one-trial step-through inhibitory avoidance task and tested for retention 24 h later. Injections were administered bilaterally (1.0 microliter/injection) through chronically-implanted cannulae. Low doses of NE (0.1 or 0.3 microgram) administered shortly after training enhanced retention while higher doses (1.0 or 5.0 micrograms) were ineffective. Retention was not affected by NE administered 3 h after training. The effect of intra-amygdala NE on retention is blocked by simultaneous administration of propranolol (0.2 microgram). This finding suggests that the memory-enhancing effect of NE may be mediated by beta-receptors. Posttraining intra-amygdala NE also attenuated the retention deficit produced by adrenal demedullation. Further, intra-amygdala injections of propranolol (0.2 microgram) blocked the enhancing effect, on retention, of posttraining s.c. injections of epinephrine. These findings suggest that activation of noradrenergic receptors in the amygdala may be involved in memory processing and may play a role in the memory-modulating effect of peripheral epinephrine. 相似文献
3.
I. Hilakivi L. Ahtee J. O. Rinne T. Taira L. M. J. Attila P. Marjamäki 《Journal of neural transmission (Vienna, Austria : 1996)》1995,102(2):139-148
Summary Rats were treated with desipramine 5mg/kg, nomifensine 10mg/kg, zimelidine 25 mg/kg or with 0.9% sodium chloride once a day during the second and third weeks after birth, and brain stem, caudate/putamen and cortical monoamines, and caudate/putamen dopamine D1 (3[H]SCH 23390) and D2 (3[H]spiroperidol) receptor binding were measured when rats were at two months of age. In the brain stem, the concentration of 3-methoxy-4-hydroxy-phenyl glycol was increased in nomifensine rats and the ratio of 5-hydroxyindoleacetic acid to 5-hydroxytryptamine was increased in zimelidine rats. In the caudate/putamen, the concentrations of 3,4-dihydroxyphenylacetic acid and homovanillic acid and the ratio of homovanillic acid to dopamine were increased in desipramine rats; neither3[H]SCH 23390 nor3[H]spiroperidol binding were affected by any of the three monoamine uptake inhibiting antidepressants studied. In the cortex, the ratio of 5-hydroxyindoleacetic acid to 5-hydroxytryptamine was increased in desipramine and zimelidine rats. The findings suggest that desipramine but not nomifensine increases the metabolism of dopamine in the caudate/ putamen and nomifensine but not desipramine increases the metabolism of norepinephrine in the brain stem, and furthermore that the metabolism of serotonin is affected by desipramine as well as by zimelidine. It is possible that also treatment of women with these drugs during late pregnancy causes long-lasting changes in the brain of human fetus. 相似文献
4.
It has been suggested that reward dependence, as measured by the Tridimensional Personality Questionnaire (TPQ), is related to central noradrenergic activity, a proposition supported by two studies of urinary norepinephrine metabolite. In the current investigation, 190 normal young Han Chinese were examined, with genetic polymorphisms determined for the norepinephrine transporter (1287G/A) and the α2c‐adrenoceptor (Del322–325) to test the association with TPQ personality traits. No significant association was demonstrated for these two polymorphisms and any of the TPQ personality‐factor scores, including reward dependence and its subscales. Our negative findings suggest that the investigated polymorphisms of the norepinephrine transporter and the α2c adrenoceptor do not play a major role in the reward‐dependence personality trait as assessed by TPQ. © 2002 Wiley‐Liss, Inc. 相似文献
5.
J. Kolanowski L. T. Younis R. Vanbutsele J. -M. Detry 《European journal of clinical pharmacology》1992,42(6):599-605
Summary The effect of dexfenfluramine (dF) on body weight, blood pressure and noradrenergic activity were studied in 30 obese hypertensive patients randomly divided into two groups and treated for 3 months either with dF (30 mg daily; 16 subjects) or placebo (Pl; 14 subjects). 11 patients from the dF group and 9 patients given Pl completed the entire experimental protocol, including monthly visits for metabolic and hormonal measurements, as well as a bicycle exercise test with arterial catheterisation for haemodynamic and catecholamine measurements performed before and after 3 months of treatment.A progressive significant decrease in body weight, averaging 6.0 kg after 3 months was observed in the dF-treated group, whereas loss of weight in the placebo group (1.4 kg) was not significant. While blood pressure and noradrenergic activity, assessed as changes in the plasma levels and urinary excretion of norepinephrine, remained unaffected in the Pl group, a significant drop in the supine systolic and diastolic blood pressures, as well as in the resting venous norepinephrine level and in urinary norepinephrine excretion was found after the first month of dF administration. In addition, the exercise-induced rise in systolic and diastolic blood pressure, as well as in arterial plasma norepinephrine and epinephrine concentrations, was significantly reduced after 3 months of dF administration; there were no such changes in the Pl-treated group.The results of the present study indicate that, in addition to the weight-reducing effect of dexfenfluramine, its hypotensive effect may be mediated by a decrease in noradrenergic activity. 相似文献
6.
7.
D. E. Uehlinger P. Weidmann M. P. Gnaedinger 《European journal of clinical pharmacology》1989,36(2):119-125
Summary Co-dergocrine has recently been demonstrated acutely to lower plasma norepinephrine (NE) and blood pressure (BP) in patients
with essential hypertension, and similar results have been obtained during chronic administration of co-dergocrine to healthy
men. The present study investigated the effect of 3 weeks of treatment with co-dergocrine 4 mg/day on BP, plasma catecholamines,
certain other BP-regulating factors and serum lipoproteins in patients with essential hypertension.
Compared to placebo conditions, co-dergocrine decreased supine BP and heart rate by −7% and the upright plasma NE level by
−24%. Supine plasma NE also fell (−24%). Total cholesterol and the LDL + VLDL-cholesterol lipoprotein fraction were lowered
by −6%.
No significant change was observed in plasma renin activity, angiotensin II, aldosterone and epinephrine levels, whole blood
and plasma volume, exchangeable sodium, and the cardiovascular responsiveness to NE, angiotensin II and isoproterenol.
The findings suggest that in patients with essential hypertension, chronic treatment with co-dergocrine may slightly decrease
sympathetic outflow and, at least in the short-term, lower the potentially atherogenic serum LDL + VLDL − cholesterol fraction. 相似文献
8.
在10只麻醉开胸犬的左前降支冠状动脉(LAD)恒流灌注,持续监测灌注压,并于冠脉内注入2.5mg心得宁以阻断心脏的β_1-肾上腺素能受体,观察去甲肾上腺素(NE,α-肾上腺素能刺激)对LAD内给予腺苷所致冠状血管舒张的限制作用。随着LAD内注入的腺苷量增加,冠状动脉阻力(R)咸剂量依赖性降低,分别为对照值的8.7%(2μg/min),20.6%(10μg/min)和28%(50μg/min)。而于LAD内再给予相同齐0量(6μg)的NE,则使不同剂量扩张的冠脉收缩,R成阶梯状增加,分别为对照值的17.4%(腺苷2μg/ml),23.2%(腺苷10μg/min)和34.1%(腺苷50μg/min),表现为隙苷引起的冠状血管扩张愈大,NE能刺激引起的缩血管作用愈强。这表明α-肾上腺素能缩血管作用可限制腺苷引起的冠状血管舒张,因而有助于保持冠状血管张力及其储备力。 相似文献
9.
10.